Search results
May 22, 2024 · The Zacks Consensus Estimate for AVTX's full-year earnings has moved 94.5% higher within the past quarter. This means that analyst sentiment is stronger and the stock's earnings outlook is improving.
May 13, 2024 · WAYNE, Pa. and ROCKVILLE, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced business updates and financial results for the first quarter of 2024 ...
May 9, 2024 · Avalo Therapeutics, Inc. is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The Company's lead asset is AVTX-009, an anti-IL-1β mAb, targeting inflammatory diseases. Its pipeline also includes quisovalimab (AVTX-002) (anti-LIGHT monoclonal antibody (mAb)) and AVTX-008 (BTLA agonist fusion protein).
6 days ago · Avalo Therapeutics, Inc. (Nasdaq: AVTX) today announced it has acquired a Phase 2-ready anti-IL-1β mAb, which it refers to as AVTX-009, through the acquisition of privately held AlmataBio, Inc. Concurrent with the acquisition, Avalo entered into a definitive agreement for the sale of preferred stock and warrants in a private placement led by Commodore Capital and TCGX, with participation from ...
May 8, 2024 · AVTX, Avalo Therapeutics - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines
6 days ago · A good PEG ratio for stocks is around 1:1. For every $1 you have invested in a stock you should expect roughly $1 back in dividends and capital gains. Some people prefer to use a 2:1 or 3:1 PEG ratio instead, but it can be too aggressive for most people. Remember, the higher the PEG ratio, the more volatile your stock portfolio will be.
May 13, 2024 · Cash on hand of approximately $110 million as of March 31, 2024 with expected cash runway into 2027. WAYNE, Pa. and ROCKVILLE, Md., May 13, 2024 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), today announced business updates and financial results for the first quarter of 2024. “Over the past month we have made considerable ...
